ARCHIVES

Low-Dose IFN Not Effective Against Melanoma, Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Bass & Howes Bought By DDB Seattle

March 22, 2002

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished

September 7, 1979

Southern Gets Two More Contracts Totaling 44.5 Million From NCI

June 14, 1974

DCBDC Board Cool to Proposals On Study Sections

November 23, 1990

Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release

April 26, 1985